The United States is a major contributor to the growth of the ambulatory infusion therapy services industry, driven by the increasing prevalence of chronic diseases such as cancer, autoimmune disorders, neurological conditions, and infectious diseases that require ongoing infusion-based treatments. The growing use of specialty drugs and biologics, combined with a strong shift toward outpatient...